NeoForce Group, Inc.
NeoForce has created the worlds first combination Resuscitator/CPAP device and has revolutionized delivery of rescue breaths during CPR.
NeoForce finds unmet needs in neonatal, pediatric and adult resuscitation and creates proprietary solutions for hospitals and first responders. Valued at $780M, the addressable market opportunity for our solutions is significant and sustainable. Baby-boomers are creating a rapidly growing aging population, resulting in increased demand for products addressing acute cardiopulmonary events with an expectation of better outcomes.